Patent granted for first new forms of MDMA, clearing path to a potential FDA approval
Terran Biosciences has been awarded a U.S. patent for the world’s first new salts and polymorphs of MDMA, pharmaceutical compositions using these forms, and the method of use for treatment of PTSD, according to a company press release. Terran Biosciences now holds the only composition of matter patent of a new form of MDMA, according to the release.